Valy Fontil1,2, Reena Gupta3, Nathalie Moise4, Ellen Chen5, David Guzman3,2, Charles E McCulloch, Kirsten Bibbins-Domingo3,6,2. 1. Division of General Internal Medicine, Zuckerberg San Francisco General Hospital (V.F., R.G., D.G., K.B.-D.) valy.fontil@ucsf.edu. 2. University of California San Francisco. UCSF Center for Vulnerable Populations at Zuckerberg San Francisco General Hospital (V.F., D.G., K.B.-D.). 3. Division of General Internal Medicine, Zuckerberg San Francisco General Hospital (V.F., R.G., D.G., K.B.-D.). 4. Department of Medicine, Columbia University Medical Center, New York, NY (N.M.). 5. San Francisco Department of Public Health, CA (E.C.). 6. Department of Epidemiology and Biostatistics (C.E.M., K.B.-D.).
Abstract
BACKGROUND: Nearly half of Americans with diagnosed hypertension have uncontrolled blood pressure (BP) while some integrated healthcare systems, such as Kaiser Permanente Northern California, have achieved control rates upwards 90%. METHODS AND RESULTS: We adapted Kaiser Permanente's evidence-based treatment protocols in a racially and ethnically diverse population at 12 safety-net clinics in the San Francisco Health Network. The intervention consisted of 4 elements: a hypertension registry, a simplified treatment intensification protocol that included fixed-dose combination medications containing diuretics, standardized BP measurement protocol, and BP check visits led by registered nurse and pharmacist staff. The study population comprised patients with hypertension who made ≥1 primary care visits within the past 24 months (n=15 917) and had a recorded BP measurement within the past 12 months. We conducted a postintervention time series analysis from August 2014 to August 2016 to assess the effect of the intervention on BP control for 24 months for the pilot site and for 15 months for 11 other San Francisco Health Network clinics combined. Secondary outcomes were changes in use of guideline-recommended medication prescribing. Rates of BP control increased at the pilot site (68%-74%; P<0.01) and the 11 other San Francisco Health Network clinic sites (69%-74%; P<0.01). Statistically significant improvements in BP control rates (P<0.01) at the 11 San Francisco Health Network clinic sites occurred in all racial and ethnic groups (blacks, 60%-66%; whites, 69%-75%; Latinos, 67%-72%; Asians, 78%-82%). Use of fixed-dose combination medications increased from 10% to 13% (P<0.01), and the percentage of angiotensin-converting enzyme inhibitor prescriptions dispensed in combination with a thiazide diuretic increased from 36% to 40% (P<0.01). CONCLUSIONS: Evidence-based system approaches to improving BP control can be implemented in safety-net settings and could play a pivotal role in achieving improved population BP control and reducing hypertension disparities.
BACKGROUND: Nearly half of Americans with diagnosed hypertension have uncontrolled blood pressure (BP) while some integrated healthcare systems, such as Kaiser Permanente Northern California, have achieved control rates upwards 90%. METHODS AND RESULTS: We adapted Kaiser Permanente's evidence-based treatment protocols in a racially and ethnically diverse population at 12 safety-net clinics in the San Francisco Health Network. The intervention consisted of 4 elements: a hypertension registry, a simplified treatment intensification protocol that included fixed-dose combination medications containing diuretics, standardized BP measurement protocol, and BP check visits led by registered nurse and pharmacist staff. The study population comprised patients with hypertension who made ≥1 primary care visits within the past 24 months (n=15 917) and had a recorded BP measurement within the past 12 months. We conducted a postintervention time series analysis from August 2014 to August 2016 to assess the effect of the intervention on BP control for 24 months for the pilot site and for 15 months for 11 other San Francisco Health Network clinics combined. Secondary outcomes were changes in use of guideline-recommended medication prescribing. Rates of BP control increased at the pilot site (68%-74%; P<0.01) and the 11 other San Francisco Health Network clinic sites (69%-74%; P<0.01). Statistically significant improvements in BP control rates (P<0.01) at the 11 San Francisco Health Network clinic sites occurred in all racial and ethnic groups (blacks, 60%-66%; whites, 69%-75%; Latinos, 67%-72%; Asians, 78%-82%). Use of fixed-dose combination medications increased from 10% to 13% (P<0.01), and the percentage of angiotensin-converting enzyme inhibitor prescriptions dispensed in combination with a thiazide diuretic increased from 36% to 40% (P<0.01). CONCLUSIONS: Evidence-based system approaches to improving BP control can be implemented in safety-net settings and could play a pivotal role in achieving improved population BP control and reducing hypertension disparities.
Authors: Andrew E Moran; Michelle C Odden; Anusorn Thanataveerat; Keane Y Tzong; Petra W Rasmussen; David Guzman; Lawrence Williams; Kirsten Bibbins-Domingo; Pamela G Coxson; Lee Goldman Journal: N Engl J Med Date: 2015-01-29 Impact factor: 91.245
Authors: Valy Fontil; Kirsten Bibbins-Domingo; Dhruv S Kazi; Stephen Sidney; Pamela G Coxson; Raman Khanna; Ronald G Victor; Mark J Pletcher Journal: J Gen Intern Med Date: 2015-03-07 Impact factor: 5.128
Authors: Ross D Feldman; Guang Y Zou; Margaret K Vandervoort; Cindy J Wong; Sigrid A E Nelson; Brian G Feagan Journal: Hypertension Date: 2009-02-23 Impact factor: 10.190
Authors: Paul Muntner; Shakia T Hardy; Lawrence J Fine; Byron C Jaeger; Gregory Wozniak; Emily B Levitan; Lisandro D Colantonio Journal: JAMA Date: 2020-09-22 Impact factor: 56.272
Authors: Brandon K Bellows; Natalia Ruiz-Negrón; Kirsten Bibbins-Domingo; Jordan B King; Mark J Pletcher; Andrew E Moran; Valy Fontil Journal: Circ Cardiovasc Qual Outcomes Date: 2019-06-05
Authors: Martin Muddu; Fred C Semitala; Isaac Kimera; Mary Mbuliro; Rebecca Ssennyonjo; Simon P Kigozi; Rodgers Katwesigye; Florence Ayebare; Christabellah Namugenyi; Frank Mugabe; Gerald Mutungi; Chris T Longenecker; Anne R Katahoire; Isaac Ssinabulya; Jeremy I Schwartz Journal: BMC Health Serv Res Date: 2022-05-25 Impact factor: 2.908